Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Postoperative chemo-radiotherapy versus chemotherapy for resected gastric cancer: a systematic review and meta-analysis.

Soon YY, Leong CN, Tey JC, Tham IW, Lu JJ.

J Med Imaging Radiat Oncol. 2014 Aug;58(4):483-96. doi: 10.1111/1754-9485.12190. Epub 2014 Jul 3. Review.

PMID:
24995607
2.

Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: a direct and adjusted indirect comparison meta-analysis.

Kumagai K, Rouvelas I, Tsai JA, Mariosa D, Lind PA, Lindblad M, Ye W, Lundell L, Schuhmacher C, Mauer M, Burmeister BH, Thomas JM, Stahl M, Nilsson M.

Eur J Surg Oncol. 2015 Mar;41(3):282-94. doi: 10.1016/j.ejso.2014.11.039. Epub 2014 Nov 27. Review.

PMID:
25491892
3.

Adjuvant therapy for gastric cancer; more questions than answers.

Leong T.

J Med Imaging Radiat Oncol. 2014 Aug;58(4):481-2. doi: 10.1111/1754-9485.12204. No abstract available.

PMID:
25104176
4.

Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis.

Malthaner RA, Wong RK, Rumble RB, Zuraw L; Members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care.

BMC Med. 2004 Sep 24;2:35. Review.

5.

Postoperative chemoradiotherapy versus postoperative chemotherapy for completely resected gastric cancer with D2 Lymphadenectomy: a meta-analysis.

Huang YY, Yang Q, Zhou SW, Wei Y, Chen YX, Xie DR, Zhang B.

PLoS One. 2013 Jul 18;8(7):e68939. doi: 10.1371/journal.pone.0068939. Print 2013. Erratum in: PLoS One. 2013;8(8). doi:10.1371/annotation/e783be87-404d-4780-9159-bfd1ade5c3a4.

6.

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.

GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, Van Cutsem E, Buyse M.

JAMA. 2010 May 5;303(17):1729-37. doi: 10.1001/jama.2010.534. Review.

PMID:
20442389
7.

Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.

Logan DM, Lochrin CA, Darling G, Eady A, Newman TE, Evans WK.

Cancer Prev Control. 1997 Dec;1(5):366-78.

PMID:
9765759
8.

Adjuvant IMRT/XELOX radiochemotherapy improves long-term overall- and disease-free survival in advanced gastric cancer.

Boda-Heggemann J, Weiss C, Schneider V, Hofheinz RD, Haneder S, Michaely H, Wertz H, Ronellenfitsch U, Hochhaus A, Wenz F, Lohr F.

Strahlenther Onkol. 2013 May;189(5):417-23. doi: 10.1007/s00066-013-0309-2. Epub 2013 Apr 6.

PMID:
23558673
9.

Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis.

Oba K, Paoletti X, Alberts S, Bang YJ, Benedetti J, Bleiberg H, Catalano P, Lordick F, Michiels S, Morita S, Ohashi Y, Pignon JP, Rougier P, Sasako M, Sakamoto J, Sargent D, Shitara K, Cutsem EV, Buyse M, Burzykowski T; GASTRIC group.

J Natl Cancer Inst. 2013 Nov 6;105(21):1600-7. doi: 10.1093/jnci/djt270. Epub 2013 Oct 9. Review.

10.

A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer.

Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, Morris DL.

Ann Surg Oncol. 2007 Oct;14(10):2702-13. Epub 2007 Jul 26. Review.

PMID:
17653801
11.

Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America.

Knight G, Earle CC, Cosby R, Coburn N, Youssef Y, Malthaner R, Wong RK; Gastrointestinal Cancer Disease Site Group.

Gastric Cancer. 2013 Jan;16(1):28-40. doi: 10.1007/s10120-012-0148-3. Epub 2012 Mar 31. Review.

PMID:
22467061
12.

Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.

Okawara G, Rusthoven J, Newman T, Findlay B, Evans W.

Cancer Prev Control. 1997 Aug;1(3):249-59.

PMID:
9765750
13.

Adjuvant chemotherapy for endometrial cancer after hysterectomy.

Johnson N, Bryant A, Miles T, Hogberg T, Cornes P.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD003175. doi: 10.1002/14651858.CD003175.pub2. Review.

14.

Neoadjuvant chemotherapy for gastric cancer: a meta-analysis of randomized, controlled trials.

Liao Y, Yang ZL, Peng JS, Xiang J, Wang JP.

J Gastroenterol Hepatol. 2013 May;28(5):777-82. doi: 10.1111/jgh.12152.

PMID:
23425049
15.

Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials.

Mi DH, Li Z, Yang KH, Cao N, Lethaby A, Tian JH, Santesso N, Ma B, Chen YL, Liu YL.

Int J Hyperthermia. 2013;29(2):156-67. doi: 10.3109/02656736.2013.768359. Review.

PMID:
23418917
16.

Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer.

Rydzewska L, Tierney J, Vale CL, Symonds PR.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD007406. doi: 10.1002/14651858.CD007406.pub3. Review.

PMID:
23235641
17.

Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials.

Xu AM, Huang L, Liu W, Gao S, Han WX, Wei ZJ.

PLoS One. 2014 Jan 30;9(1):e86941. doi: 10.1371/journal.pone.0086941. eCollection 2014. Review.

18.

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A, Gebski V; Australasian Gastro-Intestinal Trials Group.

Lancet Oncol. 2011 Jul;12(7):681-92. doi: 10.1016/S1470-2045(11)70142-5. Epub 2011 Jun 16.

PMID:
21684205
19.

Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.

Dikken JL, Jansen EP, Cats A, Bakker B, Hartgrink HH, Kranenbarg EM, Boot H, Putter H, Peeters KC, van de Velde CJ, Verheij M.

J Clin Oncol. 2010 May 10;28(14):2430-6. doi: 10.1200/JCO.2009.26.9654. Epub 2010 Apr 5.

20.

Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data.

Ronellenfitsch U, Schwarzbach M, Hofheinz R, Kienle P, Kieser M, Slanger TE, Burmeister B, Kelsen D, Niedzwiecki D, Schuhmacher C, Urba S, van de Velde C, Walsh TN, Ychou M, Jensen K.

Eur J Cancer. 2013 Oct;49(15):3149-58. doi: 10.1016/j.ejca.2013.05.029. Epub 2013 Jun 22. Review.

PMID:
23800671
Items per page

Supplemental Content

Write to the Help Desk